BIBP’s COVID-19 Vaccine Approved for Emergency Use in Nepal
On February 17 local time, the Department of Drug Administration of Nepal issued a notice to approve the Inactivated COVID-19 Vaccine (Vero Cell) developed by Beijing Institute of Biological Products Co., Ltd.(BIBP), China National Biotec Group Company Limited (CNBG), Sinopharm (BIBP’s COVID-19 Vaccine) for emergency use.
According to The notice, the Inactivated COVID-19 Vaccine (Vero Cell) developed by BIBP was approved for emergence use in Nepal.Contact us
